KP Tissue Inc. (TSE:KPT – Get Free Report)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$11.31 and traded as high as C$13.20. KP Tissue shares last traded at C$13.20, with a volume of 16,152 shares traded.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the company. Desjardins upped their target price on KP Tissue from C$12.00 to C$12.50 and gave the company a “hold” rating in a research report on Friday, May 15th. TD raised their price target on KP Tissue from C$11.00 to C$12.00 and gave the stock a “hold” rating in a report on Friday, May 15th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of C$11.62.
Get Our Latest Research Report on KPT
KP Tissue Price Performance
KP Tissue (TSE:KPT – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported C$0.22 earnings per share for the quarter. Analysts expect that KP Tissue Inc. will post 0.4398964 earnings per share for the current year.
KP Tissue Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 15th will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 6.4%. The ex-dividend date is Tuesday, June 30th. KP Tissue’s dividend payout ratio (DPR) is presently 80.00%.
Insider Activity at KP Tissue
In related news, Director David A. Spraley sold 3,668 shares of KP Tissue stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the completion of the sale, the director owned 15,712 shares of the company’s stock, valued at C$208,969.60. The trade was a 18.93% decrease in their ownership of the stock. Insiders sold a total of 6,668 shares of company stock worth $87,644 over the last three months. Insiders own 0.14% of the company’s stock.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
See Also
- Five stocks we like better than KP Tissue
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
